Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 501,445 shares of the company’s stock after purchasing an additional 3,902 shares during the quarter. Johnson & Johnson accounts for 1.6% of Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings, making the stock its 5th biggest holding. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Johnson & Johnson were worth $66,336,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. OLD Point Trust & Financial Services N A grew its position in Johnson & Johnson by 2.2% in the 2nd quarter. OLD Point Trust & Financial Services N A now owns 61,326 shares of the company’s stock valued at $8,113,000 after acquiring an additional 1,321 shares during the last quarter. Lynch & Associates IN grew its position in Johnson & Johnson by 0.9% in the 2nd quarter. Lynch & Associates IN now owns 93,710 shares of the company’s stock valued at $12,397,000 after acquiring an additional 841 shares during the last quarter. Welch & Forbes LLC grew its position in Johnson & Johnson by 0.9% in the 2nd quarter. Welch & Forbes LLC now owns 718,331 shares of the company’s stock valued at $95,028,000 after acquiring an additional 6,730 shares during the last quarter. Oakbrook Investments LLC grew its position in Johnson & Johnson by 7.4% in the 2nd quarter. Oakbrook Investments LLC now owns 136,124 shares of the company’s stock valued at $18,008,000 after acquiring an additional 9,375 shares during the last quarter. Finally, Janney Montgomery Scott LLC grew its position in Johnson & Johnson by 0.5% in the 2nd quarter. Janney Montgomery Scott LLC now owns 771,868 shares of the company’s stock valued at $102,110,000 after acquiring an additional 3,533 shares during the last quarter. 65.61% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Johnson & Johnson (JNJ) Stake Boosted by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/24/johnson-johnson-jnj-stake-boosted-by-mitsubishi-ufj-kokusai-asset-management-co-ltd.html.

Several brokerages have commented on JNJ. J P Morgan Chase & Co upped their price objective on Johnson & Johnson from $140.00 to $148.00 and gave the company an “overweight” rating in a research report on Wednesday, August 16th. Jefferies Group LLC set a $145.00 price target on Johnson & Johnson and gave the stock a “hold” rating in a research report on Tuesday, August 15th. Citigroup Inc. began coverage on Johnson & Johnson in a research report on Monday, September 25th. They set a “neutral” rating and a $140.00 price target on the stock. BMO Capital Markets reissued a “positive” rating and set a $152.00 price target (up previously from $145.00) on shares of Johnson & Johnson in a research report on Wednesday, October 18th. Finally, Royal Bank Of Canada increased their price target on Johnson & Johnson from $144.00 to $147.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and eleven have given a buy rating to the company’s stock. Johnson & Johnson currently has a consensus rating of “Hold” and an average price target of $143.70.

Johnson & Johnson (NYSE JNJ) opened at $137.29 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32. The stock has a market capitalization of $368,832.31, a price-to-earnings ratio of 19.23, a PEG ratio of 2.79 and a beta of 0.82. Johnson & Johnson has a 12-month low of $109.32 and a 12-month high of $144.35.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The firm had revenue of $19.65 billion during the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.68 EPS. research analysts forecast that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Tuesday, November 28th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date is Monday, November 27th. Johnson & Johnson’s dividend payout ratio (DPR) is currently 58.33%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Stock Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related stocks with our FREE daily email newsletter.